CN107853711A - A kind of composition with antiobesity action and preparation method thereof and purposes - Google Patents
A kind of composition with antiobesity action and preparation method thereof and purposes Download PDFInfo
- Publication number
- CN107853711A CN107853711A CN201710041405.3A CN201710041405A CN107853711A CN 107853711 A CN107853711 A CN 107853711A CN 201710041405 A CN201710041405 A CN 201710041405A CN 107853711 A CN107853711 A CN 107853711A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- powder
- composition
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 84
- 230000009471 action Effects 0.000 title claims abstract description 42
- 230000003579 anti-obesity Effects 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 39
- 239000000843 powder Substances 0.000 claims abstract description 146
- 241000218236 Cannabis Species 0.000 claims abstract description 37
- 229920002752 Konjac Polymers 0.000 claims abstract description 37
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 35
- 244000269722 Thea sinensis Species 0.000 claims abstract description 34
- 229920001202 Inulin Polymers 0.000 claims abstract description 33
- 235000009569 green tea Nutrition 0.000 claims abstract description 33
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 33
- 229940029339 inulin Drugs 0.000 claims abstract description 33
- 239000002994 raw material Substances 0.000 claims abstract description 29
- 241000219051 Fagopyrum Species 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 239000002671 adjuvant Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 8
- 230000036541 health Effects 0.000 claims description 7
- 235000015895 biscuits Nutrition 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000000443 aerosol Substances 0.000 claims description 2
- 235000009508 confectionery Nutrition 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 235000012054 meals Nutrition 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims 1
- 239000013589 supplement Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 240000008620 Fagopyrum esculentum Species 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 10
- 235000015872 dietary supplement Nutrition 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 230000007774 longterm Effects 0.000 abstract description 3
- 244000046052 Phaseolus vulgaris Species 0.000 abstract 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 abstract 1
- 210000002221 olecranon process Anatomy 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 229940079593 drug Drugs 0.000 description 7
- 208000008589 Obesity Diseases 0.000 description 6
- 235000020824 obesity Nutrition 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 235000001916 dieting Nutrition 0.000 description 5
- 230000037228 dieting effect Effects 0.000 description 5
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- 206010033307 Overweight Diseases 0.000 description 3
- 102000019280 Pancreatic lipases Human genes 0.000 description 3
- 108050006759 Pancreatic lipases Proteins 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 229940116369 pancreatic lipase Drugs 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- PWDLDBWXTVILPC-WGAVTJJLSA-N CC(C)(N)CC1=CC=CC=C1.C1O[C@@]2(COS(N)(=O)=O)OC(C)(C)O[C@H]2[C@@H]2OC(C)(C)O[C@@H]21 Chemical compound CC(C)(N)CC1=CC=CC=C1.C1O[C@@]2(COS(N)(=O)=O)OC(C)(C)O[C@H]2[C@@H]2OC(C)(C)O[C@@H]21 PWDLDBWXTVILPC-WGAVTJJLSA-N 0.000 description 2
- 244000130270 Fagopyrum tataricum Species 0.000 description 2
- 235000014693 Fagopyrum tataricum Nutrition 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- 108010064851 Plant Proteins Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000002830 appetite depressant Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical class OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229960005060 lorcaserin Drugs 0.000 description 2
- XTTZERNUQAFMOF-QMMMGPOBSA-N lorcaserin Chemical compound C[C@H]1CNCCC2=CC=C(Cl)C=C12 XTTZERNUQAFMOF-QMMMGPOBSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000021096 natural sweeteners Nutrition 0.000 description 2
- 235000019533 nutritive sweetener Nutrition 0.000 description 2
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 2
- 229960001243 orlistat Drugs 0.000 description 2
- 235000021118 plant-derived protein Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 102000009394 5-Hydroxytryptamine 2C receptors Human genes 0.000 description 1
- 108050000259 5-Hydroxytryptamine 2C receptors Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 240000006122 Chenopodium album Species 0.000 description 1
- 235000009344 Chenopodium album Nutrition 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 244000045195 Cicer arietinum Species 0.000 description 1
- 235000010523 Cicer arietinum Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 229940086609 Lipase inhibitor Drugs 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 229910003978 SiClx Inorganic materials 0.000 description 1
- 206010041969 Steatorrhoea Diseases 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- LXIUJOQXHQOBSX-UHFFFAOYSA-N acetic acid chloroethene Chemical compound ClC=C.ClC=C.CC(O)=O LXIUJOQXHQOBSX-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 235000002201 avitaminosis Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229960002233 benzalkonium bromide Drugs 0.000 description 1
- KHSLHYAUZSPBIU-UHFFFAOYSA-M benzododecinium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 KHSLHYAUZSPBIU-UHFFFAOYSA-M 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical class C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 229940103440 qsymia Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical class [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Chemical class 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004334 sorbic acid Chemical class 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 208000001162 steatorrhea Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Present invention relates particularly to a kind of composition with antiobesity action and preparation method thereof and purposes.The raw material of said composition includes：The parts by weight of fructus cannabis powder 15~35, the parts by weight of oatmeal 15~35, the parts by weight of buckwheat powder 5~25, the parts by weight of inulin 5~25, the parts by weight of konjaku powder 6~14, the parts by weight of green tea powder 6~14.The present invention takes into full account the composition and the mutual proportioning of each raw material of raw material, in said composition each raw material fructus cannabis powder, buckwheat powder, konjaku powder and olecranon bean powder cooperated under specific proportioning, collective effect, so as to play antiobesity action；Said composition is also used as the dietary supplements of obese patient；In addition, the present composition does not have toxic side effect, security higher, suitable for long-term use.
Description
Technical field
The invention belongs to medicine, health products or field of food, and in particular to a kind of composition with antiobesity action and its
Preparation method and purposes.
Background technology
With expanding economy, the living standard of people improves constantly, and overnutrition and food rich in fat intake make part
Crowd occurs fat, according to statistics, 2008, there is that 1,500,000,000 people are overweight in the adult of more than 20 years old, below the whole world in 2010 5 years old
Reachable 43,000,000 that children are overweight, it is seen then that fat to turn into global medical care problem seriously and social concern.According to WHO's
Obesity standard, from 1992 to 2012, China's adult's incidence of obesity rose to 30.1% from 14.6%, and 5~17 years old blue or green few
Year children obesity incidence of disease is 9.6%；World Health Organization's investigation is found, is ended to 2015, and the whole world has that 2,300,000,000 adults are overweight, 5
Hundred million adults suffer from obesity, and in China, obesity has had influence on the health of more than 300,000,000 Chinese, it is contemplated that following many decades China
Fat number will also increase rapidly.The worry that obesity not only brings figure jeopardizes mental health, and causes heart work(
Energy excess load, cause coronary heart disease, headstroke, cerebral thrombus, hypertension, high fat of blood, hyperglycaemia and polycystic ovary syndrome etc., and fertilizer
Fat patient's cancer probability is higher than ordinary person, seriously jeopardizes health of human body.
At present, fat-reducing mainly uses two methods of weight reduction with drugs and weight-reducing by dieting.Current slimming drugs mainly include following
Two major classes：Pancreatic lipase inhibitor and appetite inhibitor；Pancreatic lipase inhibitor he by suppress pancreatic lipase activity, and then press down
Fatty decomposition absorbs and lost weight in food processed, and appetite inhibitor is made due to that can cause nervous system adverse reaction by limitation
With.So far, through FDA approvals can long-term use of slimming drugs there was only lipase inhibitor orlistat (orlistat), 5-
Hydroxytryptamine 2C receptor stimulating agents lorcaserin (lorcaserin) and compound slimming medicine Qsymia (containing phentermine and Topiramate
Sustained release agent).However, above-mentioned slimming drugs can cause the adverse reactions such as steatorrhea, fat-soluble avitaminosis, and to brain centres
Whether toxic side effect is remained in very big uncertainty with cardiovascular system etc..Therefore, had become most by weight-reducing by dieting
Basic and safest method of weight-reducing, but there is following mistaken ideas for existing weight-reducing by dieting：On the one hand, control to no plan
Diet can make human body malnutrition, infringement health；On the other hand, motion exercise is carried out under starvation, can not only reduce fat
Fat, also muscle can be made largely to reduce on the contrary and muscle is followed the string, in some instances it may even be possible to than producing more fat before fat-reducing.Cause
This, the weight-reducing by dieting on the premise of holding nutrition equilibrium is only the desirable fat-reducing mode of science.
In order to solve the problems, such as that existing slimming drugs adverse reaction is more and toxic side effect is larger, Chinese patent literature
CN103704611A discloses the composition of following weight-reducing by dieting：A kind of tartary buckwheat compound health-care rice, its be by bitter buckwheat, glutinous rice,
Oatmeal powder, peanut, chick-pea, linseed kernel, dried longan pulp, konjaku, pumpkin flower, thorn lamb's-quarters, strawberry leaves, artist's conk, black tea powder, lily
Powder, hawthorn powder, grape pip powder, cucumber seed, saponin rice, honey-fried licorice root, fructus cannabis, rhizoma nelumbinis, cordyceps flower, loguat leaf and coix seed oil are original
Material is made；The tartary buckwheat compound health-care rice has preventing and treating hyperglycaemia, improves immunity, fat-reducing and beauty and other effects.On however,
State composition and the shortcomings of composition is complicated, composition is more be present, so as to limit its application.
Therefore, it is significant to study the Weight reducing compound that new constituent is less, security is higher.
The content of the invention
Therefore, the technical problem to be solved in the present invention is the existing composition composition complexity with antiobesity action, composition
The shortcomings of more, so as to provide a kind of new composition with antiobesity action, and then provide its preparation method and purposes.
In order to solve the above technical problems, the present invention is achieved through the following technical solutions：
The present invention provides a kind of composition with antiobesity action, and its raw material includes：
The parts by weight of fructus cannabis powder 15~35, the parts by weight of oatmeal 15~35, the parts by weight of buckwheat powder 5~25, inulin 5~
25 parts by weight, the parts by weight of konjaku powder 6~14, the parts by weight of green tea powder 6~14.
Preferably, the above-mentioned composition with antiobesity action of the present invention, its raw material include：
The parts by weight of fructus cannabis powder 20~30, the parts by weight of oatmeal 20~30, the parts by weight of buckwheat powder 10~20, inulin 10
~20 parts by weight, the parts by weight of konjaku powder 8~12, the parts by weight of green tea powder 8~12.
It is further preferred that the above-mentioned composition with antiobesity action of the present invention, its raw material include：
The parts by weight of fructus cannabis powder 25, the parts by weight of oatmeal 25, the parts by weight of buckwheat powder 15, the parts by weight of inulin 15, konjaku
The parts by weight of fine powder 10, the parts by weight of green tea powder 10；Or
The parts by weight of fructus cannabis powder 20, the parts by weight of oatmeal 30, the parts by weight of buckwheat powder 10, the parts by weight of inulin 20, konjaku
The parts by weight of fine powder 8, the parts by weight of green tea powder 12；Or
The parts by weight of fructus cannabis powder 30, the parts by weight of oatmeal 20, the parts by weight of buckwheat powder 20, the parts by weight of inulin 10, konjaku
The parts by weight of fine powder 12, the parts by weight of green tea powder 8；Or
The parts by weight of fructus cannabis powder 22, the parts by weight of oatmeal 28, the parts by weight of buckwheat powder 12, the parts by weight of inulin 18, konjaku
The parts by weight of fine powder 11, the parts by weight of green tea powder 9.
The present invention also provides a kind of preparation method of the above-mentioned composition with antiobesity action, comprises the following steps：
Fructus cannabis powder, oatmeal, buckwheat powder, inulin, konjaku powder and the green tea powder of selected parts by weight are taken respectively, are mixed
Close uniformly, produce.
The present invention, which also provides, includes the preparation of the above-mentioned composition with antiobesity action or including above-mentioned preparation method system
The preparation of standby obtained composition,
The composition adds customary adjuvant, according to common process, be made clinically acceptable tablet, capsule, dissipate
Agent, mixture, pill, granule, solution, syrup, soft extract, emplastrum, suppository, aerosol, ointment, injection, drink
Material, biscuit, candy or cake.
Preferably, the above-mentioned preparation of the present invention, the preparation is granule or biscuit.
The customary adjuvant is：Filler, disintegrant, lubricant, suspending agent, adhesive, sweetener, flavouring, anti-corrosion
Agent, matrix etc..Filler includes：Starch, pregelatinized starch, lactose, mannitol, chitin, microcrystalline cellulose, sucrose etc.；Collapse
Solution agent includes：Starch, pregelatinized starch, microcrystalline cellulose, sodium carboxymethyl starch, PVPP, low substitution hydroxyl
Third cellulose, cross-linked carboxymethyl cellulose are received；Lubricant includes：Magnesium stearate, lauryl sodium sulfate, talcum powder, dioxy
SiClx etc.；Suspending agent includes：Polyvinylpyrrolidone, microcrystalline cellulose, sucrose, agar, hydroxypropyl methyl cellulose etc.；Bonding
Agent includes, starch slurry, polyvinylpyrrolidone, hydroxypropyl methyl cellulose etc.；Sweetener includes：Nutritive sweetener and non-battalion
Nourish one's nature natural sweetener, such as glycyrrhizin, xylitol, maltitol；Flavouring includes：Nutritive sweetener and non-nutritive
Property natural sweetener and various flavoring essences；Preservative includes：Parabens, benzoic acid, sodium benzoate, sorbic acid and its salt
Class, benzalkonium bromide, acetic acid chloroethene are fixed, eucalyptus oil etc.；Matrix includes：PEG6000, PEG4000, insect wax etc..
The present invention also provide the above-mentioned composition being prepared with antiobesity action composition, above-mentioned preparation method or on
State application of the preparation of composition in the medicine with antiobesity action, health products or food is prepared.
Further, the present invention also provides the above-mentioned group being prepared with antiobesity action composition, above-mentioned preparation method
The preparation of compound or above-mentioned composition is being prepared for the application in the dietary supplements with antiobesity action.
Compared with prior art, technical scheme has the following advantages that：
(1) composition of the present invention, the composition and the mutual proportioning of each raw material of raw material, said composition are taken into full account
In each raw material fructus cannabis powder, oatmeal, buckwheat powder, inulin, konjaku powder and green tea powder the phase interworking under specific proportioning
Close, collective effect, so as to play antiobesity action；
(2) composition of the present invention, not only contained protein is quality plant protein, and contained required ammonia
The A wide selection of colours and designs of base acid, the ratio of sufficient, each essential amino acid of content are appropriate, can meet that obese patient's day takes in energy 600
~1200kcal requirement, therefore can be as the dietary supplements of obese patient；
(3) composition of the present invention, not only with significant fat-reducing effect, and without toxic side effect, security compared with
Height, suitable for long-term use；
(4) composition of the present invention, only including 6 kinds of raw materials, composition is simple, composition is less.
Embodiment
In following examples of the present invention and experimental example, fructus cannabis powder, oatmeal, buckwheat powder, inulin, konjaku powder and
Green tea powder is commercially available product.
Embodiment 1
There is the present embodiment the raw material of the composition of antiobesity action to form：Fructus cannabis powder 25g, oatmeal 25g are bitter
Buckwheat powder 15g, inulin 15g, konjaku powder 10g, green tea powder 10g；
The preparation method of said composition, comprises the following steps：Take respectively the fructus cannabis powder of selected weight, oatmeal,
Buckwheat powder, inulin, konjaku powder and green tea powder, it is well mixed, produces.
The composition that the present embodiment has antiobesity action adds customary adjuvant, and according to common process, biscuit is made.
Embodiment 2
There is the present embodiment the raw material of the composition of antiobesity action to form：Fructus cannabis powder 20g, oatmeal 30g are bitter
Buckwheat powder 10g, inulin 20g, konjaku powder 8g, green tea powder 12g；
The preparation method of said composition, comprises the following steps：Take respectively the fructus cannabis powder of selected weight, oatmeal,
Buckwheat powder, inulin, konjaku powder and green tea powder, it is well mixed, produces.
The composition that the present embodiment has antiobesity action adds customary adjuvant, and according to common process, capsule is made.
Embodiment 3
There is the present embodiment the raw material of the composition of antiobesity action to form：Fructus cannabis powder 30g, oatmeal 20g are bitter
Buckwheat powder 20g, inulin 10g, konjaku powder 12g, green tea powder 8g；
The preparation method of said composition, comprises the following steps：Take respectively the fructus cannabis powder of selected weight, oatmeal,
Buckwheat powder, inulin, konjaku powder and green tea powder, it is well mixed, produces.
The composition that the present embodiment has antiobesity action adds customary adjuvant, and according to common process, granule is made.
Embodiment 4
There is the present embodiment the raw material of the composition of antiobesity action to form：Fructus cannabis powder 22g, oatmeal 28g are bitter
Buckwheat powder 12g, inulin 18g, konjaku powder 11g, green tea powder 9g；
The preparation method of said composition, comprises the following steps：Take respectively the fructus cannabis powder of selected weight, oatmeal,
Buckwheat powder, inulin, konjaku powder and green tea powder, it is well mixed, produces.
The composition that the present embodiment has antiobesity action adds customary adjuvant, and according to common process, biscuit is made.
Embodiment 5
There is the present embodiment the raw material of the composition of antiobesity action to form：Fructus cannabis powder 15g, oatmeal 35g are bitter
Buckwheat powder 5g, inulin 25g, konjaku powder 6g, green tea powder 14g；
The preparation method of said composition, comprises the following steps：Take respectively the fructus cannabis powder of selected weight, oatmeal,
Buckwheat powder, inulin, konjaku powder and green tea powder, it is well mixed, produces.
The composition that the present embodiment has antiobesity action adds customary adjuvant, and according to common process, biscuit is made.
Embodiment 6
There is the present embodiment the raw material of the composition of antiobesity action to form：Fructus cannabis powder 35g, oatmeal 15g, hardship
Buckwheat powder 25g, inulin 5g, konjaku powder 14g, green tea powder 6g；
The preparation method of said composition, comprises the following steps：Take respectively the fructus cannabis powder of selected weight, oatmeal,
Buckwheat powder, inulin, konjaku powder and green tea powder, it is well mixed, produces.
The composition that the present embodiment has antiobesity action adds customary adjuvant, and according to common process, granule is made.
Comparative example 1
There is this comparative example the raw material of the composition of antiobesity action to form：Fructus cannabis powder 13g, oatmeal 37g are bitter
Buckwheat powder 4g, inulin 28g, konjaku powder 2g, green tea powder 16g；
The preparation method of said composition, comprises the following steps：Take respectively the fructus cannabis powder of selected weight, oatmeal,
Buckwheat powder, inulin, konjaku powder and green tea powder, it is well mixed, produces.
Comparative example 2
This comparative example differs only in embodiment 1：Fructus cannabis powder 0g；Remaining raw material composition is matched somebody with somebody with each raw material
Than same as Example 1；
The preparation method of said composition differs only in embodiment 1：Fructus cannabis powder 0g；Remaining experiment condition and
Experimental implementation is same as Example 1.
Comparative example 3
This comparative example differs only in embodiment 1：Oatmeal 0g；Remaining raw material form and each raw material proportioning with
Embodiment 1 is identical；
The preparation method of said composition differs only in embodiment 1：Oatmeal 0g；Remaining experiment condition and experiment are grasped
Make same as Example 1.
Comparative example 4
This comparative example differs only in embodiment 1：Inulin 0g, konjaku powder 0g；Remaining raw material forms and each raw material
Proportioning it is same as Example 1；
The preparation method of said composition differs only in embodiment 1：Inulin 0g, konjaku powder 0g；Remaining experiment bar
Part and experimental implementation are same as Example 1.
Comparative example 5
This comparative example differs only in embodiment 1：Buckwheat powder 0g, konjaku powder 0g, green tea powder 0g；Remaining raw material group
It is same as Example 1 into the proportioning with each raw material；
The preparation method of said composition differs only in embodiment 1：Buckwheat powder 0g, konjaku powder 0g, green tea powder 0g；
Remaining experiment condition and experimental implementation are same as Example 1.
Experimental example 1Research of the present composition to the fat-reducing effect of obese patient
1st, experiment purpose
Study fat-reducing effect of the present composition to obese patient.
2nd, experimental method
160 obese patients are selected, are randomly divided into experimental group, control group 1-6 groups and blank control group, every group 20
Example.The medication of each group is as follows：Experimental group：The composition of the preparation of embodiment 1 is taken, 3 times a day, each 10g, continuous 30
My god；Control group 1-5 groups：The composition of comparative example 1-5 preparations is taken respectively, 3 times a day, each 10g, continuous 30 days；Control group 6
Group：Fructus cannabis powder is taken, 3 times a day, each 10g, continuous 30 days；Blank control group：Placebo is taken, 3 times a day, often
Secondary 10g, continuous 30 days.During experiment, each group keeps meals and habits and customs unlimited as far as possible, it is impossible to takes other slimming drugs
Thing.
The therapeutic effect of each group is evaluated in this experiment using patient's Self-control method according to following principle：(1) it is effective：Patient's body
Again reduce 8% and more than；(2) effectively：Weight in patients reduces 5%~8%；(3) it is invalid：Pretherapy and post-treatment weight in patients, which changes, to be less than
5%.
3rd, experimental result
The specific experiment result of each group is as shown in table 1.
The specific experiment result of each group of table 1
| Group | Number of cases | Effective number of cases | Effective number of cases | Invalid number of cases | Total effective rate (%) |
| Blank control group | 20 | 0 | 1 | 19 | 5 |
| 1 group of control group | 20 | 4 | 5 | 11 | 45 |
| 2 groups of control group | 20 | 2 | 4 | 14 | 30 |
| 3 groups of control group | 20 | 3 | 3 | 14 | 30 |
| 4 groups of control group | 20 | 3 | 1 | 16 | 20 |
| 5 groups of control group | 20 | 1 | 2 | 17 | 15 |
| 6 groups of control group | 20 | 2 | 3 | 15 | 25 |
| Experimental group | 20 | 6 | 11 | 3 | 85 |
As shown in Table 1, the treatment total effective rate of (1) experimental group is 85%, the treatment total effective rate phase with blank control group
Than with significant difference；This shows that composition prepared by embodiment 1 has obvious antiobesity action；
(2) the treatment total effective rate of experimental group is 85%, is had compared with the treatment total effective rate of control group 1-6 groups notable
Sex differernce；This shows, compared with composition or fructus cannabis powder prepared by comparative example 1-5, the composition of the preparation of embodiment 1
Fat-reducing effect is more notable.
In addition, by nutrient component determining and calculate, it is known that the combination with antiobesity action that embodiment 1 is prepared
Thing, not only contained protein is quality plant protein, and the A wide selection of colours and designs of contained essential amino acid, content it is sufficient,
The ratio of each essential amino acid is appropriate, can ensure the protein and micronutrient of abundance while providing compared with low energy
The supply of (vitamin, mineral matter etc.), it can meet that obese patient's day takes in 600~1200kcal of energy requirement, Ke Yizuo
For the dietary supplements of obese patient.
4th, experiment conclusion
The present composition has significant antiobesity action, and can be as the dietary supplements of obese patient.
Obviously, above-described embodiment is only intended to clearly illustrate example, and is not the restriction to embodiment.It is right
For those of ordinary skill in the art, can also make on the basis of the above description it is other it is various forms of change or
Change.There is no necessity and possibility to exhaust all the enbodiments.And the obvious change thus extended out or
Among changing still in the protection domain of the invention.
Claims (8)
1. a kind of composition with antiobesity action, it is characterised in that its raw material includes：
The parts by weight of fructus cannabis powder 15~35, the parts by weight of oatmeal 15~35, the parts by weight of buckwheat powder 5~25, the weight of inulin 5~25
Measure part, the parts by weight of konjaku powder 6~14, the parts by weight of green tea powder 6~14.
2. the composition according to claim 1 with antiobesity action, it is characterised in that its raw material includes：
The parts by weight of fructus cannabis powder 20~30, the parts by weight of oatmeal 20~30, the parts by weight of buckwheat powder 10~20, inulin 10~20
Parts by weight, the parts by weight of konjaku powder 8~12, the parts by weight of green tea powder 8~12.
3. the composition according to claim 1 or 2 with antiobesity action, it is characterised in that its raw material includes：
The parts by weight of fructus cannabis powder 25, the parts by weight of oatmeal 25, the parts by weight of buckwheat powder 15, the parts by weight of inulin 15, konjaku powder
10 parts by weight, the parts by weight of green tea powder 10；Or
The parts by weight of fructus cannabis powder 20, the parts by weight of oatmeal 30, the parts by weight of buckwheat powder 10, the parts by weight of inulin 20, konjaku powder 8
Parts by weight, the parts by weight of green tea powder 12；Or
The parts by weight of fructus cannabis powder 30, the parts by weight of oatmeal 20, the parts by weight of buckwheat powder 20, the parts by weight of inulin 10, konjaku powder
12 parts by weight, the parts by weight of green tea powder 8；Or
The parts by weight of fructus cannabis powder 22, the parts by weight of oatmeal 28, the parts by weight of buckwheat powder 12, the parts by weight of inulin 18, konjaku powder
11 parts by weight, the parts by weight of green tea powder 9.
A kind of 4. preparation method of the composition with antiobesity action described in any one of claim 1-3, it is characterised in that bag
Include following steps：
Fructus cannabis powder, oatmeal, buckwheat powder, inulin, konjaku powder and the green tea powder of selected parts by weight are taken respectively, and mixing is
It is even, produce.
5. including the preparation of the composition with antiobesity action described in claim any one of 1-3 or including claim 4
The preparation for the composition that described preparation method is prepared, it is characterised in that
The composition adds customary adjuvant, and according to common process, clinically acceptable tablet, capsule, powder, conjunction is made
Agent, pill, granule, solution, syrup, soft extract, emplastrum, suppository, aerosol, ointment, injection, beverage, cake
Dry, candy or cake.
6. preparation according to claim 5, it is characterised in that the preparation is granule or biscuit.
7. prepared by the composition with antiobesity action described in claim any one of 1-3, the preparation method described in claim 4
The preparation of the obtained composition described in composition or claim 5 or 6 is preparing medicine, health products with antiobesity action
Or the application in food.
8. prepared by the composition with antiobesity action described in claim any one of 1-3, the preparation method described in claim 4
The preparation of the obtained composition described in composition or claim 5 or 6 is being prepared for the meal supplement with antiobesity action
Application in agent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710041405.3A CN107853711A (en) | 2017-01-19 | 2017-01-19 | A kind of composition with antiobesity action and preparation method thereof and purposes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710041405.3A CN107853711A (en) | 2017-01-19 | 2017-01-19 | A kind of composition with antiobesity action and preparation method thereof and purposes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107853711A true CN107853711A (en) | 2018-03-30 |
Family
ID=61698980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710041405.3A Pending CN107853711A (en) | 2017-01-19 | 2017-01-19 | A kind of composition with antiobesity action and preparation method thereof and purposes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107853711A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106261763A (en) * | 2016-08-11 | 2017-01-04 | 刘前锋 | A kind of grain dietary fiber meal replacement powder and preparation method thereof |
-
2017
- 2017-01-19 CN CN201710041405.3A patent/CN107853711A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106261763A (en) * | 2016-08-11 | 2017-01-04 | 刘前锋 | A kind of grain dietary fiber meal replacement powder and preparation method thereof |
Non-Patent Citations (4)
| Title |
|---|
| 丛涛等: "火麻仁蛋白质粉对生长期大鼠营养生理功能的影响研究", 《中国食品学报》 * |
| 中国农业标准汇编 果蔬卷 下: "《中国农业标准汇编 果蔬卷 下》", 31 August 2002 * |
| 张光霁等: "《肥胖症的中医药调治》", 30 September 2015, 上海科学技术出版社 * |
| 林巧等: "《苦荞制品中黄曲霉毒素的污染及控制》", 30 April 2016 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104840722A (en) | Functional health-preserving treasure composition as well as preparation method and application method thereof | |
| WO2018021886A1 (en) | Food composition for relieving hangover, overcoming fatigue and improving immunity comprising extract of mixed herbal medicine as active ingredient | |
| WO2012034498A1 (en) | Product of functional health food that enhances organ immunity | |
| CN107233442B (en) | Composition capable of improving gout discomfort symptoms and fingerprint spectrum establishment method | |
| KR101329187B1 (en) | Oriental medicine composition for chidren's anorexia and manufacturing method thereof | |
| CN105708970B (en) | A kind of health food with function of blood sugar reduction | |
| CN102406690A (en) | Traditional Chinese medicine gynostemma pentaphylla buccal tablet | |
| CN107432472B (en) | Composition for treating diarrhea and application thereof | |
| CN101658641A (en) | Health-care preparation containing gastrodia tuer, folium cortex eucommiae, and Ilex latifolia thumb and preparation method thereof | |
| CN108813610A (en) | A kind of saussurea involucrata composition and its application for improving immunity | |
| KR20160000695A (en) | Herbal-medicine containing dha for recovering fatigue and enhancing memory, and method of manufacturing the same | |
| CN101190250B (en) | Chewable tablets for preventing and controlling high-altitude disease and preparation method thereof | |
| CN105076614A (en) | Weight-reducing health protection tea | |
| CN107853711A (en) | A kind of composition with antiobesity action and preparation method thereof and purposes | |
| CN102132870B (en) | Diet health-care product and preparation method thereof | |
| CN112007122B (en) | Traditional Chinese medicine composition for tonifying primordial qi, calming heart, tonifying spleen, eliminating dampness and regulating immunity of organism and preparation method thereof | |
| CN106923335A (en) | A kind of function composition of sport nutrition and application | |
| CN102362936A (en) | Application of amorphophallus blume extract, and medicine and healthcare product solid preparation and beverage of amorphophallus blume extract | |
| CN112690449A (en) | Cereal conditioning porridge for middle-aged and old people | |
| CN101828703B (en) | Product for enhancing organic immunity and improving sleeping quality and preparation method thereof | |
| JP6698034B2 (en) | Oral composition for improving systemic symptoms such as chills | |
| CN101147612B (en) | Five health-care soft beverage | |
| CN110384757A (en) | A kind of pressed candy and purposes improving Qi deficiency physique | |
| CN104173745A (en) | Nourishing and body-building Mongolian medicine | |
| CN107334972A (en) | A kind of Chinese medicine composition with cardiovascular and cerebrovascular protective effect |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180330 |